I'm Giving Dynavax Another Shot -- a Booster Shot

Despite an earnings miss, DVAX show promise in several vaccine fronts and I'm doubling down on the name.

In This Environment, I'd Be More Risk Averse With Intuitive Surgical

The firm has been hurt and continues to be hurt by the effects of the pandemic.

CVS Stock Needs to Refill Its Prescription

Charts are looking 'toppy' right now.

The Rally in UnitedHealth Is Getting Winded

Let's check the charts and indicators.

Bausch Health's Charts Continue to Look Out of Focus

The technical signals of the diversified health care company still don't inspire confidence to establish long positions in its stock at this time.

Let's Put the IQ Healthy Hearts ETF Through Its Paces

A closer look at the fund's composition leads to a few head-scratchers, but most of the names seem to fairly represent its focus.

Could Fresh Global Outbreaks Move the Needle for Moderna?

As several parts of the world struggle with Covid-19 surges, MRNA could win in the long war against the pandemic.

Is It Safe to Climb Back Aboard the ARKK? Let's Check the Chart

ARK Innovation ETF offered a glimmer of technical hope Thursday to those following the high-growth space, plus we look at two new stocks.

GoodRx Doesn't Look So Good

Here's what it's going to take to turn the charts positive.

Bausch Health Can't Seem to Pass Its Chart Exam as Earnings Approach

Here's what the charts show for BHC as the name prepares to post earnings on Wednesday.